检索

标题
作者
The use of a urethral catheter with an ultrasound-induced biopolymer drug coating for the prevention of recurrent bladder neck sclerosis in patients after endoscopic treatment of benign prostate hyperplasia
Kamalov А., Sorokin N., Kadrev А., Shaparov B., Afanasevskaya Е., Sindeeva О., Sukhorukov G., Kritsky А., Pyataev N., Abdurashitov А., Kulikov О., Proshin P.
Study of allelic variants of the CYP2D6 and CYP3A genes on the effectiveness and safety of tamsulosin therapy in patients with BPH: results of a pilot study
Abdullaev S., Shatokhin M., Tuchkova S., Abdullaev S., Teodorovich O., Loran O., Sychev D.
The results of the multicenter prospective comparative study of Fndrogel in men with endogenous testosterone deficiency and lower urinary tract symptoms, associated with benign prostate hyperplasia («Potok»)
Kogan M., Avadieva N., Gevorkyan L., Loginov Y., Metelkin A., Mitin A., Patrikeev A.
Use of the drug Prostatex plus in patients with chronic abacterial prostatitis and BPH
Neymark A., Nozdrachev N., Kulchavenya E., Kholtobin D., Davydov A., Neymark A., Kovaleva Y., Yakovlev A.
Practical use of Adenoprosin® in combination therapy in men with lower urinary tract symptoms
Kasyan G., Khodyreva L., Grigoryan B., Dyakov V.
Evaluation of the efficacy of silodosin 8 mg in comorbid patients with LUTS/BPH
Zimichev A., Gusev D., Lukyanova D.
Management of lower urinary tract symptoms in patients with benign prostatic hyperplasia during COVID-19. results of an all-russian observational study “ATLANT”
Neymark B., Neymark A., Yakovets Y., Nozdrachev N., Ibishev K., Kuzmin I.
«LUTS/BPH - who treats?». The results of the epidemiologic study
Pushkar D., Rasner P., Aboyan I., Asfandiyarov F., Kotov S., Kogan M., Korneev I., Medvedev V., Neymark A., Novikov A., Pavlov V., Tsukanov A., Shabalkin S., Shormanov I.
Molecular genetic predictors of the efficacy and safety of tamsulosin therapy
Abdullaev S., Shatokhin M., Teodorovich O., Sychev D.
Outpatient urodynamic monitoring in patients with BPH: world and russian experience
Shaderkin I., Lebedev G., Shaderkina V., Monakov D., Spivak L., Gadzhieva Z., Gazimiev M.
Frequency and risk factors for the development of infravesical obstructions caused by surgery of benign prostatic hyperplasia
Kriuchkova N., Kogan M., Glukhov V., Mitusov V., Sizyakin D.
Modern possibilities of therapy of a urological patient with concomitant diseases of the cardiovascular system
Kuzmenko A., Kuzmenko V., Gyaurgiev T.
Patients with newly diagnosed benign prostatic hyperplasia
Meshkov I., Kulchavenya E., Shevchenko S., Neimark A.
The influence of alfuzosin monotherapy on the sexual function of patients with benign prostatic hyperplasia in real clinical practice (results of a Russian multicenter study)
Pushkar D., Loran O., Bernikov A.
Super-selective prostatic artery embolization as minimally invasive surgical treatment in patients with BPH
Karpov V., Sharapov B., Kapranov S., Zlatovratskiy A., Kamalov A.
Specific features of lower urinary tract symptoms in men living in the moscow region. Results of the epidemiological study
Pushkar D., Rasner P., Kotenko D., Gerasimov A., Shabalkin S.
A place of silodosin in the treatment of LUTS/BPH according to evidence-based medicine and real clinical practice
Kotov S., Bogdanov D.
Endoscopic enucleation of the prostate: a short term trend or a new treatment standard?
Glybochko P., Alyaev Y., Rapoport L., Enikeev D., Okhunov Z., Netsch C., Spivak L., Taratkin M.
NEW APPROACHES TO COMBINED THERAPY OF IRRITATIVE SYMPTOMS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
Ergakov D., Martov A.
RISK FACTORS FOR ANTERIOR URETHRAL STRICTURES AFTER TRANSURETHRAL RESECTION OF BENIGN PROSTATIC HYPERPLASIA
Grechenkov A., Glybochko P., Alyaev Y., Bezrukov E., Vinarov A., Butnaru D., Sukhanov R.
COMPARATIVE ANALYSIS OF THE EFFECTIVENESS OF EARLY AND DELAYED INITIATION OF COMBINED DRUG THERAPY FOR BPH
Kuzmenko A., Kuzmenko V., Gyaurgiev T.
CURRENT ISSUES IN ALPHA1-ADRENERGIC BLOCKER THERAPY: INTEGRATION OF PHARMACOLOGICAL APPROACH AND CLINICAL EXPERIENCE
Martov A., Dukhanin A., Bernikov A.
Therapeutic efficacy and safety of monotherapy Alfuprost® MR 10 mg/day in clinical practice
Novikov A., Shpilenya E.
MEDICAL TREATMENT OF PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA WITH 5A-REDUCTASE INHIBITORS
Spivak L., Platonova D., Yagudaev D.
THE ROLE OF SYSTEMATIZATION OF POSTOPERATIVE COMPLICATIONS IN ASSESSING THE EFFICIENCY AND SAFETY OF SURGICAL METHODS FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
Giyasov S., Gafarov R., Shodmonova Z., Mukhtarov S., Akilov F.
1 - 25 的 25 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##